BioSpace News Archive

Pharm Country

UZEDY™ (risperidone) Extended-Release Injectable Suspension Significantly Prolongs Time to Schizophrenia Relapse in RISE Study Results Published in The Lancet Psychiatry

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd., announced the publication of efficacy and safety findings from the phase 3 Risperidone Subcutaneous Extended-Release study in The Lancet Psychiatry.

November 1, 2023
·
19 min read
Drug Development

Kodiak Sciences Announces First Time Presentation of Primary Endpoint Data From Tarcocimab Tedromer Phase 3 GLOW Study in Patients With Diabetic Retinopathy at American Academy of Ophthalmology Annual Meeting

Kodiak Sciences Inc announced that data from tarcocimab tedromer will be presented during the annual meeting of the American Academy of Ophthalmology to be held November 3-6 in San Francisco.

November 1, 2023
·
4 min read
MEI Pharma Enters into Agreement with Anson Funds and Cable Car Capital

MEI Pharma, Inc. and Anson Funds and Cable Car Capital announced that they have entered into a cooperation agreement. Key terms of the agreement include: Capital Return to Stockholders.

November 1, 2023
·
9 min read
AI-Powered Tumor Microenvironment Analysis Predicts Treatment Outcomes in NSCLC Patients with EGFR Mutation: Groundbreaking Studies to be Presented by Lunit at SITC 2023

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced the presentation of six studies at the upcoming SITC 2023 Annual Meeting, taking place from November 1 to 5, in San Diego, California.

November 1, 2023
·
5 min read
Syantra Emerges from Stealth with AI Powered RNA-Based Immune Response Detection Liquid Biopsy Platform and Announces Rob Lozuk as CEO

Today, Syantra, a liquid biopsy platform and innovation company that is changing the way cancer is detected, starting with Syantra DXTM Breast Cancer, announced that Rob Lozuk has been appointed as Chief Executive Officer, effective November 1, 2023.

November 1, 2023
·
3 min read
BioMidwest

Zynex Announces Share Repurchase Program - November 01, 2023

Zynex, Inc. announced that its board of directors approved a program to repurchase up to $20.0 million of the Company’s common stock.

November 1, 2023
·
4 min read
Biotech Bay

New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo® Hemodialysis System on Equitable Kidney Care

Outset Medical, Inc. announced significant data findings on how the use of Tablo increases racial diversity among users, enhances patient outcomes in the Medicare fee-for-service population, and notably decreases hospital transfers in rural Alaskan communities.

November 1, 2023
·
4 min read
Biotech Beach

Genome Insight Secures $23 Million in Series B-2 Funding Round

Genome Insight announced that it has closed a $23 million in a Series B-2 investment in its latest funding round.

November 1, 2023
·
2 min read
Biotech Beach

ATEC to Participate in Upcoming Investor Conferences - November 01, 2023

Alphatec Holdings, Inc., a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced that management will participate in the following investor events.

November 1, 2023
·
1 min read
Genetown

BostonGene to Present Research with Leading Cancer Centers at Society for Immunotherapy of Cancer’s 2023 Annual Meeting

BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced the Company will present four posters at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting taking place November 3-5, 2023 at the San Diego Convention Center in San Diego, CA.

November 1, 2023
·
4 min read